Swee Y. Loh

Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates.

Lloyd R. Kelland, Prakash Mistry, G Abel et al. · PubMed · 1992 · 124 citations

Medicine, Oncology, Pharmacology +16

A phase I and pharmacology study of an oral platinum complex, JM216: dose-dependent pharmacokinetics with single-dose administration

Mark J. McKeage, Prakash Mistry, Janet Ward et al. · Cancer Chemotherapy and Pharmacology · 1995 · 98 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line.

Lloyd R. Kelland, Prakash Mistry, G Abel et al. · PubMed · 1992 · 94 citations

Medicine, Oncology, Pharmacology +17

Comparison of cellular accumulation and cytotoxicity of cisplatin with that of tetraplatin and amminedibutyratodichloro(cyclohexylamine)platinum(IV) (JM221) in human ovarian carcinoma cell lines.

Prakash Mistry, Lloyd R. Kèlland, Swee Y. Loh et al. · PubMed · 1992 · 47 citations

Medicine, Oncology, Pharmacology +16

Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian‐carcinoma cell lines

Prakash Mistry, Swee Y. Loh, Lloyd R. Kèlland et al. · International Journal of Cancer · 1993 · 40 citations

Medicine, Oncology, Pharmacology +14